Curonix is a healthcare startup focused on providing chronic pain relief below the neck, offering the promise of freedom from the implantable battery and a minimally invasive option. Founded in 2010 and headquartered in the United States, the company leverages wireless neurostimulation technology to provide cost-effective alternatives to complex surgeries, making it more accessible to a wider population. Their goal is to enhance people's lives by offering convenient and safe methods of pain relief that can be seamlessly integrated into everyday life. Currently, there is no information available regarding their last investment or the participating investors.
There is no investment information
No recent news or press coverage available for Curonix.